Session Type
Meeting
Search Results for home
Oral Presentations
Abstract Number: Oral
SHM Converge 2021
Background: “Hospital at Home” (HaH) models of care have existed for over 20 years in the U.S. Demand for healthcare value has driven renewed attention to HaH, including from the Centers for Medicare and Medicaid Services. The COVID-19 pandemic has only magnified consideration of alternative sites of care. Where studied, HaH models have had desirable […]
Abstract Number: 38
SHM Converge 2023
Background: Patients experiencing unsheltered homelessness are at extreme risk for worse outcomes, including increased mortality 10 times that of the general population and an average life expectancy of 53 (over 20 yrs less than general population). Transitions of care pose unique difficulties for this vulnerable population, with numerous barriers to ongoing care and resulting readmission […]
Abstract Number: 40
SHM Converge 2023
Background: “Hospital at Home” (HaH) models of care have existed for over 20 years in the U.S. Demand for healthcare value, advances in relevant technologies, and the ongoing global pandemic have driven renewed attention to HaH models, by way of policy-based and academic pilot programs – and even commercialization attempts. Where studied, these models have […]
Abstract Number: 91
SHM Converge 2023
Background: Lack of stable housing adversely affects health outcomes, increases healthcare utilization, and increases mortality. Few studies have assessed the prevalence of homelessness and housing insecurity in hospitalized patients. To address this gap, we conducted a hospital point-in-time study to determine the prevalence of housing insecurity and homelessness among hospitalized patients at two academic medical […]
Abstract Number: J2
SHM Converge 2022
Background: “Hospital at Home” (HaH) models of care have existed for over 20 years in the U.S. Recent demand for healthcare value, advances in relevant technologies, and the ongoing global pandemic have driven renewed attention to HaH models, including from the Center for Medicare and Medicaid Services (CMS), and have spawned several pilots within the […]
Abstract Number: 102
Hospital Medicine 2020, Virtual Competition
Background: Hospital at home (HaH) programs have shown efficacy as substitutes for high-cost, traditional hospitalization in patients who are primarily low-acuity and with a range of medical conditions, including community-acquired pneumonia (CAP) and urinary tract infection (UTI). However, wide-spread adoption is minimal as providers and patients are challenged to consider HaH at the time of […]
Abstract Number: 129
SHM Converge 2023
Background: Patients experiencing homelessness have unique healthcare needs due to barriers of care, lack of access to food and safety, and limited social services. Patients can be experiencing homelessness temporarily or chronically. They experience high rates of substance abuse, mental illness and other health problems like HIV. These unique circumstances make patients experiencing homeless unique […]
Abstract Number: 132
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Background: Despite recent advancements in the medical management of acute and chronic Heart Failure (HF), smooth transitions of care for patients hospitalized with HF remain elusive for most health care systems. Use of home health services and other ancillary services have been promoted in recent years as a means of reducing readmission rates among HF […]
Abstract Number: 137
SHM Converge 2023
Background: An estimated 580,000 individuals were experiencing homelessness during the most recent national point-in-time count. Dialysis requires substantial patient engagement, and not having secure housing impedes medical care and could increase acute care utilization. The prevalence of homelessness and its impact on hospitalizations among patients with ESKD are unknown. This retrospective cohort study examined differences […]
Abstract Number: 150
Hospital Medicine 2020, Virtual Competition
Background: Patients with immune-mediated diseases such as rheumatoid arthritis, psoriatic arthritis, or inflammatory bowel disease (IBD) are increasingly being prescribed biologics. While biologics may account for roughly 2% of total prescriptions in the United States, they account for over 35% of net drug spending and for over 80% of the growth in net drug spending.1,2 […]